Abiopharma

CAN FITE BIO (CANF) Files Form 6-K

New Form 15-12G - Cidara Therapeutics, Inc. Filed: 2026-01-20 AccNo: 0001193125-26-015957 Size: 11 KB

NervGen Pharma to Ring the Nasdaq Closing Bell on January 22, 2026, Celebrating Its Recent Nasdaq Listing

Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Me...

Can-Fite Completes Patient Enrollment in Phase 2a Pancreatic Cancer Study of Namodenoson

(99% Neutral) BioXcel Therapeutics Inc. (BTAI) Announces Regulatory Update

(99% Neutral) AIM ImmunoTech Inc. (AIM) Files Form 8-K

908 Devices Inc. - 908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025

Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17

Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results

Bristol Myers Squibb - Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer

(10% Negative) Novavax Inc (NVAX) Announces Business Combination

Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer

Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer

(99% Neutral) Trinseo SA (TSE) Announces New Board Appointment